| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) | 
|---|
| 12/18/1996 | EP0748214A1 Liposomes and use thereof especially to obtain immunomodulating compositions | 
| 12/18/1996 | EP0695171B1 Lyospheres comprising gonadotropin | 
| 12/18/1996 | EP0506914B1 Method for the diagnosis of hiv infections | 
| 12/18/1996 | CN1138298A Vaccines | 
| 12/18/1996 | CN1138295A A novel tumor suppressor gene | 
| 12/17/1996 | US5585499 Drug delivery | 
| 12/17/1996 | US5585468 Substituted thioureas as bifunctional chelators | 
| 12/17/1996 | US5585464 Recombinant antigen for diagnosing rheumatoid arthritis | 
| 12/17/1996 | US5585351 T-cadherin adhesion molecule | 
| 12/17/1996 | US5585344 Liver-derived receptors for advanced glycosylation endproducts and uses thereof | 
| 12/17/1996 | US5585268 Purified isolated dna sequence encoding specified amino acid sequence or fragment encoding polypeptide reactive with antiserum to specified plasmodium falciparum band | 
| 12/17/1996 | US5585264 Useful in vaccines to prevent disease in cattle | 
| 12/17/1996 | US5585262 Process for the production of a viable cell culture infected by a multiple sclerosis-associated virus | 
| 12/17/1996 | US5585250 Hiv-1 vaccine; variations and modifications of the v3 loop including additional glycosylation signals | 
| 12/17/1996 | US5585234 Treatment of infertile sperm in vitro with thymosin α1 to enhance penetration of mammalian ova | 
| 12/17/1996 | US5585233 Mutant; gebnetic engineering | 
| 12/17/1996 | US5585106 Nonspecific defense mechanism; administering phagocytosable particles of a particular size to enhance macrophage oxidizing activity; pretreatment for surgery, prosthetics; anticancer agents; aids | 
| 12/17/1996 | US5585103 Induction of cytotoxic T-lymphocyte responses | 
| 12/17/1996 | US5585102 Flagella-less borrelia | 
| 12/17/1996 | US5585100 Vaccine; diagnosis, therapy and prevention of disease | 
| 12/17/1996 | US5585098 Injecting fowl hen with immunogen to elicit immunoglobulin antibodies against mastitis-causing organism, administering antibodies to infected lactating ruminant | 
| 12/17/1996 | US5585097 Aglycosylated immunoglobulin g antibody; preventing renal allograft rejection | 
| 12/17/1996 | US5585096 Replication-competent herpes simplex virus mediates destruction of neoplastic cells | 
| 12/17/1996 | US5585089 Humanized immunoglobulins | 
| 12/17/1996 | CA2006684C Monoclonal antibody against protein c | 
| 12/17/1996 | CA1338800C Hepatitis delta and diagnostics and vaccines | 
| 12/16/1996 | WO1996039508A1 Fibroblast growth factor 13 | 
| 12/13/1996 | CA2178553A1 Marek's disease vaccine | 
| 12/12/1996 | WO1996039629A1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents | 
| 12/12/1996 | WO1996039541A1 Colon specific gene and protein | 
| 12/12/1996 | WO1996039540A1 Novel gene-up regulated in regenerating liver | 
| 12/12/1996 | WO1996039524A1 Methods for enhancement of protective immune responses | 
| 12/12/1996 | WO1996039515A1 Human vascular endothelial growth factor 2 | 
| 12/12/1996 | WO1996039511A2 A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR | 
| 12/12/1996 | WO1996039510A1 Chimeric proteins for use in transport of a selected substance into cells | 
| 12/12/1996 | WO1996039509A1 Fibroblast growth factor 15 | 
| 12/12/1996 | WO1996039507A1 Fibroblast growth factor 11 | 
| 12/12/1996 | WO1996039503A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY AND METHODS FOR PREPARATION | 
| 12/12/1996 | WO1996039497A1 Transforming growth factor alpha hi | 
| 12/12/1996 | WO1996039491A1 Recombinant poxvirus - cytomegalovirus compositions and uses | 
| 12/12/1996 | WO1996039485A1 Human hepatoma-derived growth factor-2 | 
| 12/12/1996 | WO1996039484A1 Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods | 
| 12/12/1996 | WO1996039442A1 G-protein receptor htnad29 | 
| 12/12/1996 | WO1996039437A1 Human g-protein chemokine receptor hdgnr10 | 
| 12/12/1996 | WO1996039427A1 Ligand-stimulated gene expression | 
| 12/12/1996 | WO1996039420A1 Human criptin growth factor | 
| 12/12/1996 | WO1996039419A1 Colon specific genes and proteins | 
| 12/12/1996 | WO1996039186A1 Anti-neutrophil cytoplasmic antibody material associated with ulcerative colitis and related methods and kits | 
| 12/12/1996 | WO1996039185A1 Treatment and diagnosis of prostate cancer | 
| 12/12/1996 | WO1996039182A1 Dual carrier immunogenic construct | 
| 12/12/1996 | WO1996039180A1 Immunogen preparation with hapten | 
| 12/12/1996 | WO1996039179A1 Novel recombinant temperature sensitive mutants of influenza | 
| 12/12/1996 | WO1996039178A1 A replication-defective adenovirus human type 5 recombinant as a vaccine carrier | 
| 12/12/1996 | WO1996039177A1 Recombinant poxvirus-calicivirus [rabbit hemorrhagic disease virus (rhdv)] compositions and uses | 
| 12/12/1996 | WO1996039176A1 USE OF ORAL TOLERANCE TO SUPPRESS BOTH Th1 AND Th2 IMMUNE RESPONSES AND TO SUPPRESS ANTIBODY PRODUCTION | 
| 12/12/1996 | WO1996039168A1 Method for increasing hdl cholesterol level | 
| 12/12/1996 | WO1996039113A2 Oral administration of pneumococcal antigens | 
| 12/12/1996 | CA2562162A1 Human g-protein chemokine receptor hdgnr10 | 
| 12/12/1996 | CA2423891A1 Novel recombinant temperature sensitive mutants of influenza | 
| 12/12/1996 | CA2413012A1 Human vascular endothelial growth factor 2 | 
| 12/12/1996 | CA2223957A1 Transforming growth factor alpha hi | 
| 12/12/1996 | CA2223950A1 Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods | 
| 12/12/1996 | CA2223733A1 Human hepatoma-derived growth factor-2 | 
| 12/12/1996 | CA2223707A1 Novel gene-up regulated in regenerating liver | 
| 12/12/1996 | CA2223439A1 Anti-neutrophil cytoplasmic antibody material associated with ulcerative colitis and related methods and kits | 
| 12/12/1996 | CA2223421A1 Methods for enhancement of protective immune responses | 
| 12/12/1996 | CA2223419A1 Recombinant poxvirus-calicivirus [rabbit hemorrhagic disease virus (rhdv)] compositions and uses | 
| 12/12/1996 | CA2223291A1 Treatment and diagnosis of prostate cancer | 
| 12/12/1996 | CA2223282A1 Recombinant poxvirus - cytomegalovirus compositions and uses | 
| 12/12/1996 | CA2223177A1 Method for increasing hdl cholesterol level | 
| 12/12/1996 | CA2223038A1 A c5a-like seven transmembrane receptor | 
| 12/12/1996 | CA2222965A1 Oral administration of pneumococcal antigens | 
| 12/12/1996 | CA2222643A1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents | 
| 12/12/1996 | CA2221798A1 Colon specific genes and proteins | 
| 12/12/1996 | CA2221795A1 Colon specific gene and protein | 
| 12/12/1996 | CA2221711A1 Chimeric proteins for use in transport of a selected substance into cells | 
| 12/12/1996 | CA2221706A1 G-protein receptor htnad29 | 
| 12/12/1996 | CA2218329A1 Fibroblast growth factor-11 | 
| 12/12/1996 | CA2217301A1 Fibroblast growth factor 15 | 
| 12/12/1996 | CA2217216A1 Human chemokine beta-13 | 
| 12/12/1996 | CA2196281A1 Dual carrier immunogenic construct | 
| 12/11/1996 | EP0747482A2 Hepatitis GB virus recombinant proteins and uses thereof | 
| 12/11/1996 | EP0747394A2 Hepatitis GB virus synthetic peptides and uses thereof | 
| 12/11/1996 | EP0747063A2 Neisseria meningitidis capsular polysaccharide conjugates | 
| 12/11/1996 | EP0747058A1 Acellular vaccine | 
| 12/11/1996 | EP0746398A1 Antibody purification | 
| 12/11/1996 | EP0746338A1 Vaccines containing paucilamellar lipid vesicles as immunological adjuvants | 
| 12/11/1996 | EP0746336A1 Prodrugs activated by targeted catalytic proteins | 
| 12/11/1996 | EP0746332A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof | 
| 12/11/1996 | EP0746329A1 Anti-inflammatory factor, method of isolation, and use | 
| 12/11/1996 | EP0583390B1 Detection of cardiovascular lesions | 
| 12/11/1996 | EP0491865B1 Conjugate vaccine for group b streptococcus | 
| 12/11/1996 | CN1137799A Glucosamine disaccharides, method for their preparation pharmaceutical composition comprising same and their use | 
| 12/11/1996 | CN1137758A Methods of prolonged suppression of humoral immunity | 
| 12/11/1996 | CN1137757A Compositions and methods for stimulating megakaryocyte growth and differentiation | 
| 12/10/1996 | US5583203 VLA proteins | 
| 12/10/1996 | US5583202 Antigenized antibodies and genes | 
| 12/10/1996 | US5583201 Using apolipoprotein e variant as marker of peripheral nerve damage | 
| 12/10/1996 | US5583112 Enhancing immune responses in animals | 
| 12/10/1996 | US5583109 Method of stimulating immune response |